RHOXF2B and chronic myelogenous leukemia, BCR-ABL1 positive: RHOXF2B was not recognized by IgG antibodies from the sera of normal donors or pre-vaccination CML patients but was recognized after primary (4 of 19 patients) and secondary vaccination series (Figure 4).